Wim De Jong
www.mendeley.com
0000-0002-4956-3141
Rijksinstituut voor Volksgezondheid en Milieu
3 papers found
Refreshing results…
Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls
Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties
Differences in the toxicity of cerium dioxide nanomaterials after inhalation can be explained by lung deposition, animal species and nanoforms
Missing publications? Search for publications with a matching author name.